Table 1 Clinical and laboratory characteristics as well as overall survival of the 305 patients with stage I–II gastric cancer after resection
Characteristic | Patients [cases (%)] | Overall survival (months)a | P b |
|---|---|---|---|
Age | <0.001 | ||
<60 years | 168 (55.1) | 132.6 (123.7–141.5) | |
≥60 years | 137 (44.9) | 110.5 (98.2–122.9) | |
Sex | 0.072 | ||
Male | 202 (66.2) | 115.7 (105.6–125.8) | |
Female | 103 (33.8) | 135.0 (123.7–146.3) | |
Tumor location in the stomach | <0.001 | ||
Upper third | 87 (28.5) | 82.0 (70.6–93.4) | |
Middle third | 59 (19.3) | 131.7 (116.4–147.1) | |
Lower third | 159 (52.1) | 133.3 (123.3–143.3) | |
Tumor size | 0.343 | ||
<3 cm | 156 (51.1) | 123.3 (112.8–133.9) | |
≥3 cm | 149 (48.9) | 121.5 (110.4–132.6) | |
TNM stage | 0.001 | ||
IA | 56 (18.4) | 108.1 (102.4–113.8) | |
IB | 53 (17.4) | 112.9 (100.5–125.3) | |
IIA | 50 (16.4) | 115.9 (98.2–133.6) | |
IIB | 146 (47.9) | 111.1 (99.0–123.2) | |
mGPSc | <0.001 | ||
0 | 158 (51.8) | 75.1 (70.5–79.6) | |
1 | 44 (14.4) | 67.4 (58.9–75.9) | |
2 | 13 (4.3) | 42.7 (25.8–59.6) | |
PNI | 0.010 | ||
0 | 282 (92.5) | 126.7 (118.8–134.7) | |
1 | 23 (7.5) | 68.5 (49.7–87.4) | |
PLT–NLR | 0.009 | ||
0 | 210 (68.9) | 128.3 (119.9–136.7) | |
1 | 78 (25.6) | 93.7 (79.5–107.8) | |
2 | 17 (5.6) | 125.3 (96.2–154.4) | |
NLR–PLR | <0.001 | ||
0 | 120 (39.3) | 142.2 (133.7–150.8) | |
1 | 96 (31.5) | 119.0 (105.5–132.5) | |
2 | 89 (29.2) | 100.9 (85.4–116.4) | |